Mannkind (MNKD) Accounts Payables (2010 - 2026)
Mannkind's (MNKD) quarterly Accounts Payables came in at $16.1 million in Q1 2026, up 220.25% year-on-year from $5.0 million in Q1 2025, and up 78.7% on a QoQ basis from $9.0 million in Q4 2025.
Mannkind (MNKD) Accounts Payables (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Accounts Payables data on file, last reported at $16.1 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 220.25% year-over-year to $16.1 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 220.25% increase from a year earlier, with the FY2025 full-year figure at $9.0 million, up 33.01% from the prior year.
- Accounts Payables for Q1 2026 stood at $16.1 million, up from $9.0 million in the prior quarter.
- Over the last five years, Accounts Payables for MNKD reached as high as $17.1 million in Q2 2023 and fell as low as $5.0 million in Q1 2025.
- Historically, Accounts Payables has averaged $10.1 million across 5 years, with a median of $9.6 million in 2024.
- Across the five-year window, Accounts Payables plunged 61.54% in 2024 and soared 220.25% in 2026, its largest moves.
- Year by year, Accounts Payables stood at $11.1 million in 2022, then dropped by 13.32% to $9.6 million in 2023, then dropped by 29.1% to $6.8 million in 2024, then soared by 33.01% to $9.0 million in 2025, then surged by 78.7% to $16.1 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $16.1 million in Q1 2026, $9.0 million in Q4 2025, and $7.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Mannkind | 1.26 Bn | 1.13 Bn | 82.66 Mn | 16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.14 Mn |
| Dec 31, 2025 | 9.03 Mn |
| Sep 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 10.26 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 9.56 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Dec 31, 2023 | 9.58 Mn |
| Sep 30, 2023 | 16.75 Mn |
| Jun 30, 2023 | 17.13 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 9.87 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 9.53 Mn |
| Jun 30, 2021 | 7.49 Mn |